PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Junichiro Ishizuka) has successfully developed a novel ...

Custom Recombinant Protein Production Services Market 2025 custom recombinant protein production services market is estimated to be valued ...

Cytonics, an early-stage biopharmaceutical company developing therapies for osteoarthritis, today announced that the last ...

1 Laboratory of Infectious Diseases and Vaccine, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China 2 Department of Healthcare Intelligence, University of North ...

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

This infographic highlights the key advantages of CHO cells and the technologies that are pushing the boundaries of cell ...

Depending on your source of health news or the slant of your social media feed, you might be getting inundated these days with info about peptide therapy. This medical treatment involves using ...

coli expression system. It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the ...

Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...

R&D Expenses: Research and development expenses for the year ended December 31, 2024 decreased to approximately $2,044,000 ...